Previous studies have demonstrated that FCN3 suppresses HCC progression through multiple mechanisms including complement activation [14], induction of ribosomal stress [15] and promotion of ferroptosis [16]. This evidence concerns the gene FCN3 and hepatocellular carcinoma.